Tomas Stojanov

Biography

  Genea Group successfully transformed from a premium IVF provider with an undeniable track record and a 30 year world leading research and development program into an international fertility company with integrated clinical, medical device and research arms, and with true global reach. The Genea virtuous circle of innovation – identified through clinical needs, R&D and commercial processes now sit at the core of Genea activities.

Research Interest

  IVF,gynecology